Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Hyperplasia 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

Megestrol Acetate 4Progestins 3Tirzepatide 2Letrozole 2Biopsy 2semaglutide 1exemestane 1Tamoxifen 1Surveys and Questionnaires 1Sampling Studies 1Restraint, Physical 1Resistance Training 1Pterocarpus marsupium 1Pharmacogenomic Variants 1Observation 1Nutrition Assessment 1Metformin 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Intrauterine Devices 1Hysteroscopy 1Hysterectomy 1Everolimus 1Estrogen Replacement Therapy 1Cyproterone acetate, ethinyl estradiol drug combination 1Curettage 1Blood Specimen Collection 13,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Hyperplasia × Curettage × 1 year × Clear all
NCT07436793 2026-02-27

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

New Mexico Cancer Research Alliance

Phase 2 Not yet recruiting
140 enrolled
Gynecologic

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡